Matthew Kelsey

Stock Analyst at HC Wainwright & Co.

(0.21)

# 4,145

Out of 4,835 analysts

Total ratings

33.33%

Success rate

-34.93%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Kelsey

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ACXP Acurx Pharmaceuticals	Assumes: Buy	$8	$0.39	+1,967.18%	1	May 15, 2025
	DBVT DBV Technologies	Maintains: Equal-Weight	$260 → $100	$11.10	+800.90%	5	Dec 20, 2018

Acurx Pharmaceuticals

May 15, 2025

Assumes: Buy

Price Target: $8

Current: $0.39

Upside: +1,967.18%

DBV Technologies

Dec 20, 2018

Maintains: Equal-Weight

Price Target: $260 → $100

Current: $11.10

Upside: +800.90%